Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Pluristem Therapeutics, Inc. (PSTI)

« Back to company index

PSTI Chatter Timeline

Stock Ticker for PSTI

Most Active Tweeters for PSTI

UserTweets
@GantosJ 7
@fierro7676 4
@AmericanBanking 3
@TickerReport 3
@ConsumerFeed 3

Recent Tweets for PSTI

ThisLincolnian @ThisLincolnian
Maxim Group Reaffirms Buy Rating for Pluristem Therapeutics $PSTI https://t.co/A3RRgeAX3h
December 7th 2019, 11:12am
ConsumerFeed @ConsumerFeed
Pluristem Therapeutics $PSTI Rating Reiterated by Maxim Group https://t.co/V1hzcSXSJF
December 6th 2019, 4:12am
GantosJ @GantosJ
$PSTI is an important part of RESTORE.... Competing for an award up to €1 billion over the next 10 years by the Eu… https://t.co/02SxB4i82a
December 5th 2019, 9:12am
TickerReport @TickerReport
Pluristem Therapeutics’ $PSTI “Buy” Rating Reaffirmed at Maxim Group https://t.co/AV3gQKXEra
December 4th 2019, 2:12pm
AmericanBanking @AmericanBanking
Maxim Group Reiterates “Buy” Rating for Pluristem Therapeutics $PSTI https://t.co/HhJb6yLn0l #stocks
December 4th 2019, 2:12pm
MaisaCorp @MaisaCorp
$PSTI has enrolled half of the targeted 240 patients for the ongoing phase 3 trial of its placenta-based cell thera… https://t.co/LtSib7KAeu
December 3rd 2019, 6:12pm
GantosJ @GantosJ
So we got the continuation candlestick today in $PSTI & closing at the HoD $3.80 on large volume Waiting for BARDA… https://t.co/cjMqNXgOmA
December 3rd 2019, 4:12pm
LifeSciAdvisors @LifeSciAdvisors
Pluristem $PSTI Reaches Milestone in its Phase III Muscle Injury Study, Completes 50% Enrollment https://t.co/wIsIAJECSW
December 3rd 2019, 3:12pm
fierro7676 @fierro7676
RT @GantosJ: $PSTI Many patients do not fully recover after surgery, suffering considerable morbidity due to poor muscle regeneration and i…
December 3rd 2019, 3:12pm
fierro7676 @fierro7676
RT @GantosJ: $PSTI Currently no approved treatments for the post-operative regeneration of injured or weak skeletal muscle & up to 30% of…
December 3rd 2019, 3:12pm
fierro7676 @fierro7676
$PSTI looks ready to run https://t.co/ZpZ9zpkzcC
December 3rd 2019, 3:12pm
GantosJ @GantosJ
$PSTI breaking out the 50MA & downtrend line & closing above them. We need a confirmation candle today thoug Next t… https://t.co/n9XTtr9yZk
December 3rd 2019, 8:12am
GantosJ @GantosJ
$PSTI Many patients do not fully recover after surgery, suffering considerable morbidity due to poor muscle regener… https://t.co/A6fRbNRxWA
December 3rd 2019, 8:12am
GantosJ @GantosJ
$PSTI Currently no approved treatments for the post-operative regeneration of injured or weak skeletal muscle & up… https://t.co/oDOyxNFvzF
December 3rd 2019, 7:12am
Gambiste1 @Gambiste1
RT @Optionsavvy: $PSTI looking perky premarket at 3.66
December 3rd 2019, 7:12am
otcdynamics @otcdynamics
$PSTI Pluristem Reaches Milestone in its Phase III Muscle Injury Study, Completes 50% Enrollment https://t.co/idVPKce7vI
December 3rd 2019, 7:12am
Optionsavvy @Optionsavvy
$PSTI looking perky premarket at 3.66
December 3rd 2019, 7:12am
catfish456 @catfish456
PSTI - 3.61 Pre-market now at 3.66/3.70 Pluristem Completes 50% Enrollment In Phase III PLX-PAD Mus $PLX $PSTI… https://t.co/IoU0Kik9bR
December 3rd 2019, 7:12am
GantosJ @GantosJ
$PSTI Reaches Milestone in its Ph-3 Muscle Injury Study, Completes 50% Enrollment Multinational study in the U.S.,… https://t.co/rs2MVCdp3q
December 3rd 2019, 7:12am
DekmarTrades @DekmarTrades
$ALDX and $PSTI are the two best PRs of 7am.
December 3rd 2019, 7:12am
VisualStockRSRC @VisualStockRSRC
$PSTI - Pluristem Reaches Milestone in its Phase III Muscle Injury Study, Completes 50% Enrollment https://t.co/Umgvd1EY7s
December 3rd 2019, 7:12am
ThisLincolnian @ThisLincolnian
Pluristem Therapeutics $PSTI Trading 7.8% Higher https://t.co/vQLXchkUTW
December 2nd 2019, 8:12pm
WeekHerald @WeekHerald
Pluristem Therapeutics $PSTI Trading Up 7.8% https://t.co/7B5Lz1Xy7p
December 2nd 2019, 8:12pm
dailypoliticaln @dailypoliticaln
Pluristem Therapeutics Inc. $PSTI Expected to Post Earnings of -$0.80 Per Share https://t.co/wkTuQ8SA1w
December 1st 2019, 7:12pm
dispatchtribune @dispatchtribune
Short Interest in Pluristem Therapeutics Inc. $PSTI Drops By 22.1% https://t.co/ooz12IQRrw
November 29th 2019, 6:11pm
OlympiaReport @OlympiaReport
Short Interest in Pluristem Therapeutics Inc. $PSTI Drops By 22.1% https://t.co/Mlqemf85Ci
November 29th 2019, 6:11pm
dailypoliticaln @dailypoliticaln
Pluristem Therapeutics Inc. $PSTI Short Interest Update https://t.co/DHx1ogAa0W
November 29th 2019, 5:11pm
TickerReport @TickerReport
Pluristem Therapeutics Inc. $PSTI Short Interest Update https://t.co/L1015mj0qJ
November 29th 2019, 5:11pm
ZolmaxNews @ZolmaxNews
-$0.80 Earnings Per Share Expected for Pluristem Therapeutics Inc. $PSTI This Quarter https://t.co/kU8PVPVE6h
November 29th 2019, 4:11pm
Gambiste1 @Gambiste1
RT @botpicks: Should I Go Long or Short $PSTI ?
November 29th 2019, 3:11am
botpicks @botpicks
Should I Go Long or Short $PSTI ?
November 29th 2019, 1:11am
ConsumerFeed @ConsumerFeed
Pluristem Therapeutics Inc. $PSTI Short Interest Down 22.1% in November https://t.co/ynCn3cEsGY
November 27th 2019, 3:11pm
AmericanBanking @AmericanBanking
Pluristem Therapeutics Inc. $PSTI Short Interest Down 22.1% in November https://t.co/jeTVl36IIb #stocks
November 27th 2019, 3:11pm
WatchlistN @WatchlistN
Pluristem Therapeutics Inc. $PSTI Short Interest Down 22.1% in November https://t.co/dKiTqZeE8n
November 27th 2019, 3:11pm
PatentGrants @PatentGrants
$PSTI Pluristem Therapeutics granted European patent number EP2697362 titled "METHODS AND SYSTEMS FOR HARVESTING CE… https://t.co/jCn8iZ8RwN
November 27th 2019, 11:11am
ConsumerFeed @ConsumerFeed
Pluristem Therapeutics Inc. $PSTI Expected to Post Earnings of -$0.80 Per Share https://t.co/jx3Ajc7cuJ
November 27th 2019, 5:11am
bbnsnews @bbnsnews
Zacks: Brokerages Anticipate Pluristem Therapeutics Inc. $PSTI to Post -$0.80 EPS https://t.co/F8ToSFT9mO
November 27th 2019, 5:11am
fierro7676 @fierro7676
RT @GantosJ: $PSTI Stochastics breaking out its downtrend line, usually used as an early indicator of share-price breaking out downtrend li…
November 26th 2019, 11:11am
GantosJ @GantosJ
$PSTI Stochastics breaking out its downtrend line, usually used as an early indicator of share-price breaking out d… https://t.co/GyELWQPtzQ
November 26th 2019, 11:11am
stocknewstimes @stocknewstimes
Editas Medicine $EDIT vs. Pluristem Therapeutics $PSTI Head to Head Analysis https://t.co/PBcqJomHAt
November 26th 2019, 3:11am
TheMarketsDaily @TheMarketsDaily
Reviewing Editas Medicine $EDIT and Pluristem Therapeutics $PSTI https://t.co/e0LcJNjoJN
November 26th 2019, 3:11am
AmericanBanking @AmericanBanking
-$0.80 Earnings Per Share Expected for Pluristem Therapeutics Inc. $PSTI This Quarter https://t.co/Awm3jxdUJQ #stocks
November 24th 2019, 7:11pm
TheMarketsDaily @TheMarketsDaily
Zacks: Analysts Anticipate Pluristem Therapeutics Inc. $PSTI Will Announce Earnings of -$0.80 Per Share https://t.co/G4tntZ3rb8
November 24th 2019, 7:11pm
dakotafinancial @dakotafinancial
-$0.80 Earnings Per Share Expected for Pluristem Therapeutics Inc. $PSTI This Quarter https://t.co/9GyGu34rxn
November 24th 2019, 7:11pm
dakotafinancial @dakotafinancial
Pluristem Therapeutics $PSTI Share Price Crosses Above Two Hundred Day Moving Average of $2.55 https://t.co/MvOVb1UJQr
November 24th 2019, 7:11am
TickerReport @TickerReport
Head to Head Survey: Pluristem Therapeutics $PSTI and Editas Medicine $EDIT https://t.co/jXbKQYpvB0
November 24th 2019, 4:11am
dailypoliticaln @dailypoliticaln
Pluristem Therapeutics $PSTI Shares Cross Above Two Hundred Day Moving Average of $2.55 https://t.co/TDIREuLwen
November 22nd 2019, 7:11pm
ZolmaxNews @ZolmaxNews
Pluristem Therapeutics $PSTI Stock Crosses Above 200-Day Moving Average of $2.55 https://t.co/Q9J0bZIVit
November 22nd 2019, 6:11pm
intercooleronli @intercooleronli
HC Wainwright Reaffirms Buy Rating for Pluristem Therapeutics $PSTI https://t.co/eeOJX4URIH #investingnews
November 18th 2019, 1:11am
ledgerzette @ledgerzette
HC Wainwright Reaffirms Buy Rating for Pluristem Therapeutics $PSTI https://t.co/olRufcg4rd #stocks
November 18th 2019, 1:11am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.